PDA

View Full Version : FDA puts strict limits on Johnson & Johnson Covid-19 vaccine



O Donna
6th May 2022, 03:17
https://cdn.mos.cms.futurecdn.net/CrLWZ9F52LrqoDKJZdKJwk-1200-80.jpg

Coronavirus (COVID-19) Update: FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals

For Immediate Release:
May 05, 2022

Today, the U.S. Food and Drug Administration has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, and to individuals 18 years of age and older who elect to receive the Janssen COVID-19 Vaccine because they would otherwise not receive a COVID-19 vaccine.

Key Points:

After conducting an updated analysis, evaluation and investigation of reported cases, the FDA has determined that the risk of thrombosis with thrombocytopenia syndrome (TTS), a syndrome of rare and potentially life-threatening blood clots in combination with low levels of blood platelets with onset of symptoms approximately one to two weeks following administration of the Janssen COVID-19 Vaccine, warrants limiting the authorized use of the vaccine.
The FDA has determined that the known and potential benefits of the vaccine for the prevention of COVID-19 outweigh the known and potential risks for individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, and for individuals 18 years of age and older who elect to receive the Janssen COVID-19 Vaccine because they would otherwise not receive a COVID-19 vaccine.
The Fact Sheet for Healthcare Providers Administering Vaccine now reflects the revision of the authorized use of the Janssen COVID-19 Vaccine and includes a warning statement at the beginning of the fact sheet for prominence which summarizes information on the risk for TTS. Additionally, information on the revision to the authorized use of the vaccine and updated information on this risk of blood clots with low levels of blood platelets has been added to the Fact Sheet for Recipients and Caregivers.

Source and further info here (https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-limits-use-janssen-covid-19-vaccine-certain-individuals)

..............................................

I suspect related news will filter out to the public as the months and years pass.

It should have always been an individual choice to vax or not and when or when not to IMO.

As well as

Going forward.

But there is a long game in play.

Satori
6th May 2022, 13:37
The FDA is dividing up the market share between the purveyors of poison. Thrombosis and TTS are known serious adverse events with all of these products, not just JJ. JJ is being squeezed out of the under 18 market, which is being given to Pfizer, and Moderna to a lesser extent. That’s my take away.

yelik
6th May 2022, 17:44
Limiting the use of these killshots is too late.

The world is now facing a catostrophic biological health crises which Governments knew over a year ago yet they carried on and on. They all knowingly signed up for mass depopulation through this very elaborate technology that may not be an entirely human concoction. The immune system of the vaccinated has been trashed making them highly vulnerable to covid strains because their immune sytem will be bypassed. It is also likely the vaccinated are themselves harbouring and spreading new strains. In effect the vaccinated my either generate their own strain which will cause serious harm or death or they may well release another pathagen to finish the job, a sort of biological binary weapon. I don't think there is much can be done to stop this because it is unlikely this dominant spiked protein will ever go away

Matthew
6th May 2022, 18:22
Is this the truth leaking out by virtue of righteousness? Or is this a planted distraction? I'd like the think the FDA is acting in good faith but I can't get there at the moment.